These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15578091)

  • 1. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
    Jain A; Ma CA; Lopez-Granados E; Means G; Brady W; Orange JS; Liu S; Holland S; Derry JM
    J Clin Invest; 2004 Dec; 114(11):1593-602. PubMed ID: 15578091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
    Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
    J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
    Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
    J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase.
    Zhu Y; Nonoyama S; Morio T; Muramatsu M; Honjo T; Mizutani S
    J Med Dent Sci; 2003 Mar; 50(1):41-6. PubMed ID: 12715918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
    Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.
    Jain A; Ma CA; Liu S; Brown M; Cohen J; Strober W
    Nat Immunol; 2001 Mar; 2(3):223-8. PubMed ID: 11224521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 cross-linking induces Ig epsilon germline transcripts in B cells via activation of NF-kappaB: synergy with IL-4 induction.
    Iciek LA; Delphin SA; Stavnezer J
    J Immunol; 1997 May; 158(10):4769-79. PubMed ID: 9144491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate domains of AID are required for somatic hypermutation and class-switch recombination.
    Shinkura R; Ito S; Begum NA; Nagaoka H; Muramatsu M; Kinoshita K; Sakakibara Y; Hijikata H; Honjo T
    Nat Immunol; 2004 Jul; 5(7):707-12. PubMed ID: 15195091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
    Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
    J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.
    Imai K; Slupphaug G; Lee WI; Revy P; Nonoyama S; Catalan N; Yel L; Forveille M; Kavli B; Krokan HE; Ochs HD; Fischer A; Durandy A
    Nat Immunol; 2003 Oct; 4(10):1023-8. PubMed ID: 12958596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB family of transcription factor facilitates gene conversion in chicken B cells.
    Kim Y; Tian M
    Mol Immunol; 2009 Oct; 46(16):3283-91. PubMed ID: 19699530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects.
    Durandy A; Revy P; Imai K; Fischer A
    Immunol Rev; 2005 Feb; 203():67-79. PubMed ID: 15661022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil.
    Kavli B; Andersen S; Otterlei M; Liabakk NB; Imai K; Fischer A; Durandy A; Krokan HE; Slupphaug G
    J Exp Med; 2005 Jun; 201(12):2011-21. PubMed ID: 15967827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.
    Pasqualucci L; Kitaura Y; Gu H; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):395-400. PubMed ID: 16387847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.